In parallel with this, PDK1 could serve well in the field of cancer biomarker discovery, and more specifically act as a pharmacodynamic (PD) biomarker, in order to measure the biological activity of a protein-target, following treatment with an inhibitor- candidate. Here, PDK1 is linked to cancer.